Stock listing
Munich:9IP1 Rocket Pharmaceuticals, Inc. Aktie
German listing (Munich) of Rocket Pharmaceuticals, Inc. · home listing NASDAQ:RCKT
Follow Rocket Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RCKT
$2.44 USD -0.10 (-3.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RCKT
- Day range
- $2.37 – $2.57 USDOct 30, 2026
- Volume
- 1.54M sharesOct 30, 2026
- Market cap
- $267.9M USDAt the close on Oct 30, 2026 · price × 109.8M shares outstanding
- 52-week range
- $2.17 – $5.45 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $5.46M USDMedian day 1.66M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RCKT · Home | $2.44 USD | -0.10 (-3.9%) | 1,535,033 | $2.50 | $2.57 | $2.37 | $2.54 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:RCKT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.44 | -0.10 | -3.9% | $2.50 | $2.57 | $2.37 | 1,535,033 | |
| $2.54 | -0.04 | -1.6% | $2.58 | $2.67 | $2.50 | 1,829,544 | |
| $2.58 | +0.13 | +5.3% | $2.42 | $2.605 | $2.372 | 1,418,501 | |
| $2.45 | +0.17 | +7.5% | $2.29 | $2.52 | $2.253 | 2,054,567 | |
| $2.28 | -0.01 | -0.4% | $2.29 | $2.291 | $2.22 | 1,514,755 | |
| $2.29 | -0.02 | -0.9% | $2.27 | $2.29 | $2.17 | 1,601,100 | |
| $2.31 | +0.11 | +5.0% | $2.20 | $2.34 | $2.18 | 2,163,500 | |
| $2.20 | -0.14 | -6.0% | $2.34 | $2.385 | $2.17 | 2,022,800 | |
| $2.34 | +0.10 | +4.5% | $2.24 | $2.37 | $2.20 | 1,889,400 | |
| $2.24 | +0.06 | +2.8% | $2.18 | $2.29 | $2.165 | 1,850,300 | |
| $2.18 | -0.18 | -7.6% | $2.36 | $2.36 | $2.17 | 1,966,800 | |
| $2.36 | +0.15 | +6.8% | $2.22 | $2.395 | $2.207 | 1,878,200 | |
| $2.21 | -0.09 | -3.9% | $2.26 | $2.295 | $2.18 | 2,009,400 | |
| $2.30 | -0.18 | -7.3% | $2.47 | $2.55 | $2.26 | 3,891,300 | |
| $2.48 | -0.08 | -3.1% | $2.54 | $2.595 | $2.46 | 2,302,700 | |
| $2.56 | -0.07 | -2.7% | $2.59 | $2.688 | $2.54 | 3,369,700 | |
| $2.63 | +0.095 | +3.7% | $2.78 | $2.78 | $2.52 | 3,455,900 | |
| $2.535 | +0.055 | +2.2% | $2.45 | $2.64 | $2.42 | 2,808,500 | |
| $2.48 | -0.13 | -5.0% | $2.61 | $2.62 | $2.46 | 1,788,300 | |
| $2.61 | +0.05 | +2.0% | $2.59 | $2.63 | $2.50 | 1,658,500 | |
| $2.56 | -0.03 | -1.2% | $2.64 | $2.66 | $2.53 | 1,818,400 | |
| $2.59 | -0.04 | -1.5% | $2.62 | $2.745 | $2.58 | 2,091,900 | |
| $2.63 | +0.04 | +1.5% | $2.62 | $2.73 | $2.55 | 2,526,800 | |
| $2.59 | -0.02 | -0.8% | $2.63 | $2.646 | $2.56 | 1,153,100 | |
| $2.61 | +0.015 | +0.6% | $2.57 | $2.62 | $2.51 | 2,074,000 | |
| $2.595 | -0.095 | -3.5% | $2.80 | $2.80 | $2.57 | 2,626,700 | |
| $2.69 | -0.33 | -10.9% | $3.00 | $3.025 | $2.66 | 4,382,300 | |
| $3.02 | -0.33 | -9.9% | $3.33 | $3.335 | $2.953 | 2,777,400 | |
| $3.35 | +0.08 | +2.4% | $3.29 | $3.41 | $3.28 | 1,072,800 | |
| $3.27 | -0.10 | -3.0% | $3.40 | $3.405 | $3.265 | 1,355,300 | |
| $3.37 | -0.13 | -3.7% | $3.47 | $3.56 | $3.35 | 1,597,900 | |
| $3.50 | +0.02 | +0.6% | $3.59 | $3.755 | $3.48 | 1,858,400 | |
| $3.48 | +0.07 | +2.1% | $3.565 | $3.57 | $3.40 | 2,644,200 | |
| $3.41 | -0.02 | -0.6% | $3.65 | $3.685 | $3.21 | 3,660,100 | |
| $3.43 | +0.08 | +2.4% | $3.29 | $3.475 | $3.29 | 1,293,400 | |
| $3.35 | -0.13 | -3.7% | $3.52 | $3.52 | $3.25 | 1,655,900 | |
| $3.48 | -0.15 | -4.1% | $3.62 | $3.63 | $3.44 | 1,185,400 | |
| $3.63 | -0.08 | -2.2% | $3.67 | $3.755 | $3.62 | 871,400 | |
| $3.71 | -0.15 | -3.9% | $3.78 | $3.782 | $3.68 | 754,700 | |
| $3.86 | +0.07 | +1.8% | $3.75 | $3.88 | $3.73 | 888,500 | |
| $3.79 | -0.07 | -1.8% | $3.90 | $3.915 | $3.69 | 1,070,300 | |
| $3.86 | +0.13 | +3.5% | $3.71 | $3.955 | $3.71 | 1,162,500 | |
| $3.73 | +0.01 | +0.3% | $3.72 | $3.805 | $3.674 | 948,700 | |
| $3.72 | -0.14 | -3.6% | $3.77 | $3.80 | $3.636 | 1,601,600 | |
| $3.86 | +0.24 | +6.6% | $3.61 | $3.99 | $3.53 | 3,454,300 | |
| $3.62 | -0.04 | -1.1% | $3.63 | $3.76 | $3.59 | 1,258,500 | |
| $3.66 | -0.12 | -3.2% | $3.73 | $3.73 | $3.58 | 1,120,200 | |
| $3.78 | +0.25 | +7.1% | $3.54 | $3.81 | $3.536 | 2,201,500 | |
| $3.53 | +0.02 | +0.6% | $3.53 | $3.55 | $3.375 | 913,300 | |
| $3.51 | +0.03 | +0.9% | $3.52 | $3.605 | $3.48 | 939,800 | |
| $3.48 | -0.17 | -4.7% | $3.60 | $3.659 | $3.43 | 1,111,200 | |
| $3.65 | +0.31 | +9.3% | $3.41 | $3.66 | $3.40 | 1,439,300 | |
| $3.34 | -0.06 | -1.8% | $3.33 | $3.421 | $3.27 | 1,091,000 | |
| $3.40 | -0.07 | -2.0% | $3.47 | $3.47 | $3.36 | 1,509,000 | |
| $3.47 | +0.13 | +3.9% | $3.33 | $3.50 | $3.27 | 1,159,100 | |
| $3.34 | -0.07 | -2.1% | $3.42 | $3.446 | $3.31 | 1,108,900 | |
| $3.41 | -0.09 | -2.6% | $3.49 | $3.55 | $3.40 | 954,000 | |
| $3.50 | -0.14 | -3.8% | $3.66 | $3.67 | $3.37 | 1,697,600 | |
| $3.64 | +0.03 | +0.8% | $3.60 | $3.71 | $3.54 | 1,360,600 | |
| $3.61 | +0.07 | +2.0% | $3.53 | $3.615 | $3.465 | 1,322,100 | |
| $3.54 | +0.04 | +1.1% | $3.52 | $3.62 | $3.49 | 2,119,600 | |
| $3.50 | +0.06 | +1.7% | $3.46 | $3.52 | $3.38 | 1,981,500 | |
| $3.44 | +0.03 | +0.9% | $3.39 | $3.53 | $3.33 | 2,083,000 | |
| $3.41 | +0.30 | +9.6% | $3.13 | $3.475 | $3.03 | 3,167,800 | |
| $3.11 | -0.10 | -3.1% | $3.185 | $3.21 | $3.05 | 1,281,500 | |
| $3.21 | +0.07 | +2.2% | $3.14 | $3.21 | $3.11 | 1,126,200 |
- Ticker
- Munich:9IP1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 15, 2026
Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Latest deck · Oct 6, 2026
Corporate Update (October 2026)
Corporate update · 23 slides
Calls
Replays
Rocket Pharmaceuticals (NASDAQ:RCKT) Q2 2021 Earnings Call
Mon, Aug 09, 2021 · 4:30 PM ET
Watch Transcript
Latest news
Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Oct 15, 2026
Closed $2.36 (+6.8%) on Oct 15, 2026
Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar
Oct 7, 2026
Closed $2.54 (+2.2%) on Oct 7, 2026
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital
Oct 6, 2026
Closed $2.54 (+2.2%) on Oct 7, 2026
Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
Sep 15, 2026
Closed $3.41 (-0.6%) on Sep 15, 2026
Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
Aug 10, 2026
Closed $3.50 (-3.8%) on Aug 11, 2026
Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease
Aug 3, 2026
Closed $3.41 (+9.6%) on Aug 3, 2026
Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
Jun 12, 2026
Closed $2.75 (+3.4%) on Jun 12, 2026
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
May 7, 2026
Closed $3.63 (-1.1%) on May 8, 2026
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
Apr 28, 2026
Closed $3.43 (-1.7%) on Apr 28, 2026
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I
Mar 30, 2026
Closed $3.45 (-8.6%) on Mar 30, 2026
Financings
Term loan credit facility with warrants
Oct 6, 2026
Tranche closed: US$35M raised · warrants to purchase shares of Rocket's common stock · LifeSci Capital +1
Dealers: LifeSci Capital, PJT
Buyers: Hercules Capital, Inc. (credit facility for up to $150 million; $35 million funded at closing)
Use of proceeds: Support the pivotal Phase 2 study of RP-A501 for Danon disease and advance the broader cardiovascular pipeline
Decks
Corporate Update (October 2026)
Corporate update · 23 slides · Oct 6, 2026
Investor Presentation (August 2026)
Investor deck · 34 slides · August 2026
Technical Presentation (May 2025)
Technical · 19 slides · May 15, 2025
Technical Presentation (November 2024)
Technical · 15 slides · Nov 18, 2024
Rocket Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 182 in all · newest Oct 15, 2026 · oldest 2019
- Calls
- 1 call with a replay · 1 with a transcript · latest Aug 9, 2021
- Decks
- 40 decks · latest Oct 6, 2026
Where Rocket Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RCKT · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2JA9Q | LS Exchange | Germany | EUR |
| gettex:9IP1 | gettex | Germany | EUR |
| Lang & Schwarz:A2JA9Q | Lang & Schwarz | Germany | EUR |
| BOATS:RCKT | BOATS | United States | USD |
| Tradegate:9IP1 | Tradegate | Germany | EUR |
| Dusseldorf:9IP1 | Dusseldorf | Germany | EUR |
| Frankfurt:9IP1 | Frankfurt | Germany | EUR |
| Hamburg:9IP1 | Hamburg | Germany | EUR |
| Munich:9IP1 · This page | Munich | Germany | EUR |
| Stuttgart:9IP1 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Rocket Pharmaceuticals, Inc.